ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

HBIO Harvard Bioscience Inc

2.17
0.00 (0.00%)
Pre Market
Last Updated: 09:34:20
Delayed by 15 minutes
Share Name Share Symbol Market Type
Harvard Bioscience Inc NASDAQ:HBIO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.17 2.12 3.47 4 09:34:20

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

14/02/2024 2:00pm

Edgar (US Regulatory)


SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_____________

 

SCHEDULE 13G

(Rule 13d-102)

 

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT

TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

 

(AMENDMENT NO. 2)*

 

Harvard Bioscience Inc.

(Name of Issuer)

 

Common

(Title of Class of Securities)

 

416906105

(CUSIP Number)

 

December 31, 2023

(Date of Event Which Requires Filing of This Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

[X]Rule 13d-1(b)
[  ]Rule 13d-1(c)
[  ]Rule 13d-1(d)

 

____________________

 

*       The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 

 

 

CUSIP NO.     416906105 13G Page 2 of 5 Pages

 

1

NAMES OF REPORTING PERSONS S.S. OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS

 

82-0566501

 
2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 

 

(a) [  ]

(b) [  ]

3

SEC USE ONLY 

 

 
4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Minnesota

 

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON WITH

5

SOLE VOTING POWER

 

2,918,034

 
6

SHARED VOTING POWER

 

0

 
7

SOLE DISPOSITIVE POWER

 

2,918,034

 
8

SHARED DISPOSITIVE POWER

 

0

 

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,918,034

 
10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW 9 EXCLUDES CERTAIN SHARES

 

 

[  ]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

6.80%

 
12

TYPE OF REPORTING PERSON

 

1A

 

 

 

CUSIP NO.     416906105 13G Page 3 of 5 Pages

 

Item 1.(a) Name of Issuer:

 

Harvard Bioscience Inc.

 

(b)Address of Issuer’s Principal Executive Offices:

 

84 October Hill rd.

Holliston, MA 01746

 

Item 2.(a) Name of Person Filing:

 

Punch & Associates Investment Management, Inc.

 

(b)Address of Principal Business Office or, if None, Residence:

 

7701 France Ave. So., Suite 300

Edina, MN 55435

 

(c)Citizenship:

 

Minnesota

 

(d)Title of Class of Securities:

 

Common

 

(e)CUSIP Number:

 

416906105

 

Item 3.If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:

 

  (a) [   ] Broker or dealer registered under Section 15 of the Exchange Act.
       
  (b) [   ] Bank as defined in Section 3(a)(6) of the Exchange Act.
       
  (c) [   ] Insurance company as defined in Section 3(a)(19) of the Exchange Act.
       
  (d) [   ] Investment company registered under Section 8 of the Investment Company Act.
       
  (e [X] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
       
  (f) [   ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
       
  (g) [   ] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
       
  (h) [   ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
       
  (i) [   ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
       
  (j) [   ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

 

 

CUSIP NO.     416906105 13G Page 4 of 5 Pages

 

Item 4.Ownership.

 

(a) Amount beneficially owned: 2,918,034
(b) Percent of class: 6.80%
(c) Number of shares as to which the person has:  
  (i) Sole power to vote or to direct the vote: 2,918,034
  (ii) Shared power to vote or to direct the vote: 0
  (iii) Sole power to dispose or to direct the disposition of: 2,918,034
  (iv) Shared power to dispose or to direct the disposition of: 0

     

Item 5.Ownership of Five Percent or Less of a Class.

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  ]

 

Item 6.Ownership of More than Five Percent on Behalf of Another Person.

 

Not applicable

 

Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

 

Not applicable

 

Item 8.Identification and Classification of Members of the Group.

 

Not applicable

 

Item 9.Notice of Dissolution of Group.

 

Not applicable

 

 

CUSIP NO.     416906105 13G Page 5 of 5 Pages

 

Item 10.Certification.

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

  Punch & Associates Investment Management, Inc.  
       
  By: /s/ Howard D. Punch, Jr.  
  Name: Howard D. Punch, Jr.  
  Title: President  
       
  Date:  January 18, 2024  

 


1 Year Harvard Bioscience Chart

1 Year Harvard Bioscience Chart

1 Month Harvard Bioscience Chart

1 Month Harvard Bioscience Chart